Table 1.
Study population characteristics.
| Characteristics | EG | CG |
|---|---|---|
| Patients (n) | 19 | 15 |
| Age (y) | 61.4 ± 7.4 | 64.2 ± 4.5 |
| BMI (kg/m2) | 26.2 ± 3.0 | 26.8 ± 2.7 |
| Preoperative PSA (ng/mL) | 8.3 ± 3.9 | 8.2 ± 3.6 |
| T stage | ||
| pT2b | 2 (10.6) | 2 (13.4) |
| pT2c | 7 (36.8) | 7 (46.6) |
| pT2a | 4 (21) | 1 (6.6) |
| pT2b | 3 (15.8) | 2 (13.4) |
| pT2c | 3 (15.8) | 3 (20) |
| Gleason score | 6.7 ± 0.5 | 6.5 ± 0.5 |
| Duration of catheterization (d) | 8.6 ± 1.8 | 9.9 ± 1.9 |
EG: experimental group; CG: control group; BMI: Body Mass Index; PSA: Prostate Specific Antigen; T stage: the stage of prostate cancer—TNM system (T: tumor; N: nodes; M: metastasized); Data presented as mean ± SD or numbers with percentages in parentheses.